Company / EPS (Diluted)
Ensign Group EPS (Diluted) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
$3.65
FY2025
5-year range
$1.97 / $3.95
FY2021-FY2025
Trend
-7.6%
vs FY2024
Sector context
#42 of 159
Health Care
What the data says
At $3.65, Ensign Group's eps (diluted) ranks #42 of 159 in the Health Care sector. EPS (Diluted) has fluctuated over the past 10 years, ranging from $0.77 in FY2019 to $3.95 in FY2024.
Based on SEC 10-K filings.
3.65 in FY2025 with a 5-year CAGR of +16.5%.
Improved from $3.42 to $3.65 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +16.5%
- 10-Year CAGR
- -
Sector benchmark
#42 of 159 in Health CareTop 26% of 159This company $3.65 Sector average $1.56
▼
+134.5% above sector average
Key checks
Key Insights
- In FY2025, eps (diluted) decreased 7.6% year-over-year.
- Ranks #42 out of 159 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2024.
- Lowest eps (diluted) in the period was in FY2019.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.65 | -7.6% |
| FY2024 | $3.95 | +15.5% |
| FY2023 | $3.42 | +11.8% |
| FY2022 | $3.06 | +55.3% |
| FY2021 | $1.97 | +15.9% |
| FY2020 | $1.70 | +120.8% |
| FY2019 | $0.77 | -19.8% |
| FY2018 | $0.96 | -9.4% |
| FY2017 | $1.06 | +35.9% |
| FY2016 | $0.78 | +44.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026